Spontaneous abortion
|
phenotype |
Female Urogenital Diseases and Pregnancy Complications
|
Pathologic Function
|
188
|
|
0.100 |
None |
|
0 |
|
|
|
Intermenstrual heavy bleeding
|
phenotype |
Pathological Conditions, Signs and Symptoms; Female Urogenital Diseases and Pregnancy Complications
|
Sign or Symptom
|
10
|
1
|
0.100 |
None |
|
0 |
|
|
|
Joint swelling
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Finding
|
33
|
|
0.100 |
None |
|
0 |
|
|
|
Gingival Hemorrhage
|
phenotype |
Pathological Conditions, Signs and Symptoms; Stomatognathic Diseases
|
Pathologic Function
|
50
|
2
|
0.100 |
None |
|
0 |
|
|
|
Gastrointestinal Hemorrhage
|
phenotype |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Pathologic Function
|
122
|
24
|
0.100 |
None |
|
0 |
|
|
|
Epistaxis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Respiratory Tract Diseases; Otorhinolaryngologic Diseases
|
Pathologic Function
|
82
|
4
|
0.100 |
None |
|
0 |
|
|
|
FIBRINOGEN MILANO XII, DIGENIC PHENOTYPE
|
disease |
|
Finding
|
1
|
1
|
0.100 |
None |
|
0 |
1
|
|
|
Complement Factor I (C3 inactivator) deficiency
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Immune System Diseases
|
Disease or Syndrome
|
6
|
12
|
0.100 |
None |
|
0 |
3
|
|
|
Cerebral Hemorrhage
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Cardiovascular Diseases
|
Pathologic Function
|
122
|
78
|
0.100 |
None |
|
0 |
|
|
|
Hereditary Diffuse Gastric Cancer
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
312
|
119
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Keloid
|
disease |
Pathological Conditions, Signs and Symptoms; Skin and Connective Tissue Diseases
|
Acquired Abnormality
|
165
|
15
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Stomach Neoplasms
|
group |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
820
|
55
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Pancreatitis
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
502
|
80
|
0.200 |
None |
1.000 |
1 |
|
2010 |
2010 |
Pulmonary Embolism
|
disease |
Respiratory Tract Diseases; Cardiovascular Diseases
|
Pathologic Function
|
93
|
16
|
0.200 |
None |
1.000 |
1 |
|
2012 |
2012 |
Obesity
|
disease |
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
2821
|
1111
|
0.200 |
None |
1.000 |
1 |
|
2012 |
2012 |
Injury of liver
|
disease |
Digestive System Diseases; Wounds and Injuries
|
Injury or Poisoning
|
36
|
|
0.200 |
None |
1.000 |
1 |
|
2015 |
2015 |
Inflammation
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Pathologic Function
|
467
|
|
0.200 |
None |
1.000 |
1 |
|
2001 |
2001 |
Liver Cirrhosis, Experimental
|
disease |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Experimental Model of Disease
|
870
|
|
0.200 |
None |
1.000 |
1 |
|
2006 |
2006 |
fibrinogen activity
|
phenotype |
|
Molecular Function
|
26
|
63
|
0.100 |
None |
1.000 |
1 |
1
|
2011 |
2011 |
Bleeding tendency
|
phenotype |
Hemic and Lymphatic Diseases
|
Pathologic Function
|
71
|
14
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Fibrinogen, CTCAE
|
phenotype |
|
Finding
|
26
|
63
|
0.100 |
None |
1.000 |
1 |
1
|
2011 |
2011 |
Glycine measurement
|
phenotype |
|
Laboratory Procedure
|
32
|
68
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Cerebral atrophy
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Disease or Syndrome
|
454
|
44
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Storage disease
|
group |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
28
|
1
|
0.010 |
None |
1.000 |
1 |
1
|
2015 |
2015 |
Cerebral cortical atrophy
|
disease |
|
Disease or Syndrome
|
271
|
13
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |